Announced Mon, 15 Jun · 18:34 IST
Open Offer for 26% stake in Parmax Pharma from public shareholders
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.1%1-day move
₹62.28
prior close
₹65.39
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+7.1+9.2+11.4+13.6+15.9+20.6+41.2+58.9——
Up moveDown movePending
AI summary
Dhiren Chandulal Shah and Sunil Chinubhai Shah (Acquirers), along with 10 Persons Acting in Concert, have launched an Open Offer to acquire up to 23,46,250 equity shares (26% of expanded voting share capital) of Parmax Pharma from public shareholders. Fedex Securities is the Manager to the Offer. The Detailed Public Statement dated June 13, 2026 was published on June 15, 2026 in Financial Express, Jansatta, and Mumbai Lakshdeep newspapers.
Likely market impact
Open offer triggered for 26% stake. Public shareholders can tender shares at the offer price as detailed in the published DPS.